CTOs on the Move

Nuo Therapeutics

www.nuot.com

 
Nuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers (bedsores).
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.nuot.com
  • 207A Perry Parkway Suite 1
    Gaithersburg, MD USA 20877
  • Phone: 866.298.6633

Executives

Name Title Contact Details

Similar Companies

Circaid Medical Products Inc

Circaid Medical Products Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Orthodontics

Global Orthodontics is a Fairfax, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ifa united I tech

ifa united I tech is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson`s Disease, Essential Tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.

Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.